|
CENPN expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.848100E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.188410E-01 |
| Normal-vs-Stage2 |
1.958850E-01 |
| Normal-vs-Stage3 |
1.498910E-03 |
| Normal-vs-Stage4 |
2.982700E-04 |
| Stage1-vs-Stage2 |
4.628200E-01 |
| Stage1-vs-Stage3 |
2.350400E-02 |
| Stage1-vs-Stage4 |
1.662200E-03 |
| Stage2-vs-Stage3 |
8.305200E-01 |
| Stage2-vs-Stage4 |
7.879600E-02 |
| Stage3-vs-Stage4 |
2.977600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.441500E-04 |
| Normal-vs-AfricanAmerican |
1.508830E-01 |
| Normal-vs-Asian |
2.013000E-01 |
| Caucasian-vs-AfricanAmerican |
6.053800E-01 |
| Caucasian-vs-Asian |
9.362400E-01 |
| AfricanAmerican-vs-Asian |
8.916000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.049100E-04 |
| Normal-vs-Female |
1.529500E-02 |
| Male-vs-Female |
1.166760E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.725450E-01 |
| Normal-vs-Age(41-60Yrs) |
1.263120E-03 |
| Normal-vs-Age(61-80Yrs) |
7.438400E-03 |
| Normal-vs-Age(81-100Yrs) |
4.943600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.919200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.043200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.296600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.016400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.008200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.351400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.918000E-01 |
| Normal-vs-Grade 2 |
5.333000E-01 |
| Normal-vs-Grade 3 |
5.228600E-04 |
| Normal-vs-Grade 4 |
2.596000E-04 |
| Grade 1-vs-Grade 2 |
8.386400E-01 |
| Grade 1-vs-Grade 3 |
3.746400E-01 |
| Grade 1-vs-Grade 4 |
4.578700E-03 |
| Grade 2-vs-Grade 3 |
6.965100E-04 |
| Grade 2-vs-Grade 4 |
4.241100E-04 |
| Grade 3-vs-Grade 4 |
1.498240E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
9.160200E-01 |
| Normal-vs-ccB subtype |
6.30440000000121E-05 |
| ccA subtype-vs-ccB subtype |
2.02019999999692E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.279100E-03 |
| Normal-vs-N1 |
2.595300E-03 |
| N0-vs-N1 |
3.038400E-04 |
|
|
